Search
forResearch 10 of 789
- Association of JAK 1 and JAK 2 gene polymorphism with alopecia areata risk: a case–control genetic study
- Translational Positioning of Janus Kinase (JAK) Inhibitors in Alopecia Areata
- Genes and Immune Response in Alopecia Areata: Review of the Alopecia Areata Research Summit First Day Proceedings
- Revolutionary Approaches to Hair Regrowth: Follicle Neogenesis, Wnt/ß-Catenin Signaling, and Emerging Therapies
- Oral ruxolitinib induces hair regrowth in patients with moderate-to-severe alopecia areata
- Alopecia Areata: a Comprehensive Review of Pathogenesis and Management
- Janus Kinase inhibitors in dermatology: a review
- Clinical Perspectives on Alopecia: From Hair Follicle Biology to Advanced Therapies
- 69 Risk-benefit appraisal of systemic JAK inhibitors for alopecia areata: a comprehensive meta-analysis assessing safety and adverse effects
- 54022 Pooled Safety Assessments from the Multinational Phase 3 THRIVE-AA1 and THRIVE-AA2 Trials of Deuruxolitinib in Adult Patients with Moderate to Severe Alopecia Areata
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →